Rodney F. Minchin
Brisbane, QLD, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications
Clinical Function Assignment of NAT2 Alleles by the Clinical Pharmacogenetics Implementation Consortium Pharmacogene Curation Expert Panel.
Journal: Clinical pharmacology and therapeutics
Published: January 27, 2026
PharmVar GeneFocus: NAT2-Genetic Variation and Updated Nomenclature.
Journal: Clinical pharmacology and therapeutics
Published: July 30, 2025
Arylamine N-acetyltransferase 1 expression predicts glucose dependence and mitochondrial bioenergetics in cancer cells.
Journal: Biochimica et biophysica acta. Molecular cell research
Published: December 02, 2024
Small Molecule Inhibitors of Arylamine N-Acetyltransferase 1 Attenuate Cellular Respiration.
Journal: ACS pharmacology & translational science
Published: May 14, 2024
A PEGylated liposomal formulation of prochlorperazine that limits brain exposure but retains dynamin II activity: A potential adjuvant therapy for cancer patients receiving chemotherapeutic mAbs.
Journal: Nanomedicine : nanotechnology, biology, and medicine
Published: September 26, 2023
The Arylamine N-Acetyltransferases as Therapeutic Targets in Metabolic Diseases Associated with Mitochondrial Dysfunction.
Journal: Pharmacological reviews
Published: August 30, 2023
Dose-Dependent Effect of Phenothiazines as Dynamin II Inhibitors on the Uptake of PEGylated Liposomes by Endocytic Cells and In Vivo Pharmacokinetics of PEGylated Liposomal Doxorubicin in Rats.
Journal: Molecular pharmaceutics
Published: August 07, 2023
Dose-Dependent Production of Anti-PEG IgM after Intramuscular PEGylated-Hydrogenated Soy Phosphatidylcholine Liposomes, but Not Lipid Nanoparticle Formulations of DNA, Correlates with the Plasma Clearance of PEGylated Liposomal Doxorubicin in Rats.
Journal: Molecular pharmaceutics
Published: May 31, 2023
Arylamine N-acetyltransferase 1 deficiency inhibits drug-induced cell death in breast cancer cells: switch from cytochrome C-dependent apoptosis to necroptosis.
Journal: Breast cancer research and treatment
Published: May 05, 2022
Polymorphism in the human arylamine N-acetyltransferase 1 gene 3'-untranslated region determines polyadenylation signal usage.
Journal: Biochemical pharmacology
Published: January 25, 2022
A chameleonic macrocyclic peptide with drug delivery applications.
Journal: Chemical science
Published: May 27, 2021
Last Updated: 09/26/2026